We are developing a new BIOMIMESYS® hydroscaffold for neuronal cells. First results are very promising because neurons grow and form neurites. Moreover cells lived longer than in monolayer culture. We are currently finalizing this new hydroscaffold to find the best conditions of 3D neuron culture, but BIOMIMESYS® Brain will be soon on the market!

Luhmes cell in BIOMIMESYS® Brain, day 20 after seeding at 100 000 cells per well (Maximal Projection)

Same as above but Z by Z (Z step 10 µm)

BIOMIMESYS® Brain could be use to develop healthy or pathological models, which will be more relevant than existing monolayer models, by including the cellular microenvironnement. Moreover the long survival of cells in the hydroscaffold will allow studying chronic effect of molecules (toxics or therapeutics) on the brain. Therefore BIOMIMESYS® Brain could be very interesting model for in vitro studies of complexe neuronal diseases like Parkinson or Alzheimer disease!

If you are interested in BIOMIMESYS® Brain, feel free to contact us for more informations !



Grégory MAUBON is Chief Data Officer and digital coordinator at HCS Pharma, a biotech startup focused in high content screening and complex diseases. He manages IT missions and leads digital usages linked to company needs. He is also a Augmented Reality Evangelist (presenter and lecturer) since 2008, where he created www.augmented-reality.fr and founded in 2010 RA'pro (the augmented reality promotion association). He helped many companies (in several domains) to define precisely their augmented reality needs and supported them in the implementation.


Leave a Reply

Your email address will not be published. Required fields are marked *

%d bloggers like this: